Recent developments in mycobacterial research

Current Opinion in Infectious Diseases

Volumn 12, Issue 5, 1999, Pages 415-424

  Steyn, Andries J C ^a   Chan, John ^b   Mehra, Vijay ^c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c INTERNATIONAL AIDS VACCINE INITIATIVE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMYCOBACTERIAL AGENT; BACTERIAL PROTEIN; BCG VACCINE; DNA VACCINE; IMMUNOLOGICAL ADJUVANT; IMMUNOMODULATING AGENT; LIVE VACCINE; MYCOBACTERIUM ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC RESISTANCE; BACTERIAL GENETICS; BACTERIUM CULTURE; CHROMOSOME; DRUG DESIGN; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; GENOME; HOST RESISTANCE; HUMAN; IMMUNITY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; REVIEW; TUBERCULOSIS;

EID: 0032805930     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-199910000-00002     Document Type: Review

References (77)

1. 1 Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998; 393:537-544. The complete genome sequence of M. tuberculosis H37Rv is the first product of the Pathogen Genome Unit at the Sanger Centre. Comparing this genome with those of M. tuberculosis CDC1551, M. bovis AF2122/97, M. leprae and M. avium will provide a rich source of information for future research.
2. 2 Brosch R, Gordon SV, Billault A, Garnier T, Eiglmeier K, Soravito C, et al. Use of a Mycobacterium tuberculosis H37Rv bacterial artificial chromosome library for genome mapping, sequencing, and comparative genomics. Infect Immun 1998; 66:2221-2229. In this paper the authors demonstrate the advantages and practical implementation of bacterial artificial chromosomes. Several chromosomal polymorphisms between M. tuberculosis, M. bovis and M. bovis BCG were revealed.
3. 3 Cole ST. Comparative mycobacterial genomics. Curr Opin Microbiol 1998; 1:1567-571.
4. 4 Cole ST, Barrell BG. Analysis of the genome of Mycobacterium tuberculosis H37Rv. Novartis Found Symp 1998; 217:160-172.
5. 5 Ramakrishnan L, Falkow S. American Society for Microbiology 99th General Meeting, Chicago; 31 May 1999; abstract B/D-99. Washington DC: ASM Press; 1994.
6. 6 Cole ST. Learning from the genome sequence of Mycobacterium tuberculosis H37Rv. FEBS Lett 1999; 452:7-10.
7. 7 Mizrahi V, Andersen SJ. DNA repair in Mycobacterium tuberculosis. What have we learnt from the genome sequence? Mol Microbiol 1998; 29:1331-1339.
8. 8 Bishai W. The Mycobacterium tuberculosis genomic sequence: anatomy of a master adaptor. Trends Microbiol 1998; 6:464-465.
9. 9 Smith DR, Richterich P, Rubenfield M, Rice PW, Butler C, Lee HM, et al. Multiplex sequencing of 1.5 Mb of Mycobacterium leprae genome. Genome Res 1997; 7:802-819.
10. 10 Fleischman R. Microbial Genomes III; Chantilly, 29 January-1 February 1999. Rockville MD: TIGR; 1999.
11. 11 Zumarraga M, Bigi F, Alito A, Romano MI, Cataldi A. A 12.7 kb fragment of the Mycobacterium tuberculosis genome is not present in Mycobacterium bovis. Microbiology 1999; 145:893-897.
12. 12 Gordon SV, Brosch R, Billault A, Garnier T, Eiglmeier K, Cole ST. Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays. Mol Microbiol 1999; 32:643-655. This paper illustrates the use of BACs for whole-genome comparisons. The authors were able to demonstrate the presence of several deletions in M. tuberculosis, M. bow's and BCG.
13. 13 Gingeras TR, Ghandour G, Wang E, Berno A, Small PM, Drobniewski F, et al. Simultaneous genotyping and species identification using hybridization pattern recognition analysis of generic Mycobacterium DNA arrays. Genome Res 1998; 8:435-448.
14. 14 Behr MA, Small PM. A historical and molecular phylogeny of BCG strains. Vaccine 1999; 17:915-922.
15. 15 Behr MA, Wilson MA, Gill WP, Salamon H, Schoolnik GK, Rane S, Small PM. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 1999; 284:1520-1523. This article reports the results of a comprehensive analysis on the genomes of M. tuberculosis H37Rv, BCG and M. bovis and highlights the power of DNA microarrays to rapidly examine genetic differences between closely related bacteria.
16. 16 Urquhart BL, Atsalos TE, Roach D, Basseal DJ, Bjellqvist B, Britton WL, Humphery-Smith I. 'Proteomic contigs' of Mycobacterium tuberculosis and Mycobacterium bovis (BCG) using novel immobilised pH gradients. Electrophoresis 1997; 18:1384-1392.
17. 17 Urquhart BL, Cordwell SJ, Humphery-Smith I. Comparison of predicted and observed properties of proteins encoded in the genome of Mycobacterium tuberculosis H37Rv. Biochem Biophys Res Commun 1998; 253:70-79.
18. 18 Sturgill-Koszycki S, Haddix PL, Russell DG. The interaction between Mycobacterium and the macrophage analyzed by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis 1997; 18:2558-2565.
19. 19 Pelicic V, Reyrat JM, Gicquel B. Genetic advances for studying Mycobacterium tuberculosis pathogenicity. Mol Microbiol 1998; 28:413-420.
20. 20 Pelicic V, Jackson M, Reyrat JM, Jacobs WR Jr, Gicquel B, Guilhot C. Efficient allelic exchange and transposon mutagenesis in Mycobacterium tuberculosis. Proc Natl Acad Sci USA 1997; 94:10955-10960.
21. 21 Bardarov S, Kriakov J, Carriere C, Yu S, Vaamonde C, McAdam RA, et al. Conditionally replicating mycobacteriophages: a system for transposon delivery to Mycobacterium tuberculosis. Proc Natl Acad Sci USA 1997; 94:10961-10966.
22. 22 Rubin EJ, Akerley BJ, Novik VN, Lampe DJ, Husson RN, Mekalanos JJ. In vivo transposition of mariner-based elements in enteric bacteria and mycobacteria. Proc Natl Acad Sci USA 1999; 96:1645-1650.
23. 23 Hensel M, Shea JE, Gleeson C, Jones MD, Dalton E, Holden DW. Simultaneous identification of bacterial virulence genes by negative selection. Science 1995; 269:400-403.
24. 24 Talaat A et al. American Society for Microbiology 99th General Meeting; Chicago 31 May, Washington DC: ASM Press; 1999; abstract B/D-15.
25. 25 Heithoff DM, Conner CP, Hentschel U, Govantes F, Hanna PC, Mahan MJ. Coordinate intracellular expression of Salmonella genes induced during infection. J Bacteriol 1999; 181:799-807.
26. 26 Valdivia RH, Falkow S. Probing bacterial gene expression within host cells. Trends Microbiol 1997; 5:360-363.
27. 27 Barker LP, Brooks DM, Small PL. The identification of Mycobacterium marinum genes differentially expressed in macrophage phagosomes using promoter fusions to green fluorescent protein. Mol Microbiol 1998; 29:1167-1177.
28. 28 Smith I et al. 34th US Japan Cooperative Medical Science Program; San Francisco, 27-30 June 1999. Maryland, USA: National Institute of Allergy and Infections, National Institute of Health; in press.
29. 29 Alland D, Kramnik I, Weisbrod TR, Otsubo L, Cerny R, Miller LP, et al. Identification of differentially expressed mRNA in prokaryotic organisms by customized amplification libraries (DECAL): the effect of isoniazid on gene expression in Mycobacterium tuberculosis. Proc Natl Acad Sci USA 1998; 95:13227-13232.
30. 30 Alland D et al., 34th US Japan Cooperative Medical Science Program; San Francisco, 27-30 June 1999. Maryland, USA: National Institute of Allergy and Infections, National Institute of Health; in press.
31. 31 Rivera-Marrero CA, Burroughs MA, Masse RA, Vannberg FO, Leimbach DL, Roman J, Murtagh JJ Jr. Identification of genes differentially expressed in Mycobacterium tuberculosis by differential display PCR. Microb Pathol 1998; 25:307-316.
32. 32 Clark-Curtiss JE and Graham JE, 34th US Japan Cooperative Medical Science Program; San Francisco, 27-30 June 1999. Maryland, USA: National Institute of Allergy and Infections, National Institute of Health; in press.
33. 33 Mazzaccaro RJ, Stenger S, Rock KL, Porcelli SA, Brenner MB, Modlin RL, Bloom BR. Cytotoxic T lymphocytes in resistance to tuberculosis. Adv Exp Med Biol 1998; 452:85-101. This is a good review elucidating the critical role of both classical MHC class I and non-classical CD1 restricted T lymphocytes in lysing M. tuberculosis infected macrophages.
34. 34 Ehiers S. Immunity to tuberculosis: a delicate balance between protection and pathology. FEMS Immunol Med Microbiol 1999; 23:149-158.
35. 35 Bellamy R, Ruwende C, Corrah T, McAdam KP, Whittle HC, Hill AV. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med 1998; 338:640-644.
36. 36 Kramnik I, Demant P, Bloom BR. Susceptibility to tuberculosis as a complex genetic trait: analysis using recombinant congenic strains of mice. Novartis Found Symp 1998; 217:120-131.
37. 37 Bellamy RJ, Hill AV. Host genetic susceptibility to human tuberculosis. Novartis Found Symp 1998;217:3-13.
38. 38 Blackwell JM. Genetics of host resistance and susceptibility to intramacrophage pathogens: a study of multicase families of tuberculosis, leprosy and leishmaniasis in north-eastern Brazil. Int J Parasitol 1998; 28:21-28. This is a detailed analysis of the ganes involved in resistance and susceptibility to M. tuberculosis and M. leprae.
39. 39 Altare F, Durandy A, Lammas D, Emile JF, Lamhamedi S, Le Deist F, et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 1998; 280:1432-1435. This study is the first evidence of the crucial role of IFN-γ and IL-12 in protective immunity against mycobacterial infection.
40. 40 Orme IM. New vaccines against tuberculosis. The status of current research. Infect Dis Clin North Am 1999; 13:169-185. This study provides a critical analysis of the rationale and design of vaccine approaches for tuberculosis.
41. 41 Weldingh K, Andersen P. Immunological evaluation of novel Mycobacterium tuberculosis culture filtrate proteins. FEMS Immunol Med Microbiol 1999; 23:159-164.
42. 42 Liu MA, Fu TM, Donnelly JJ, Caulfield MJ, Ulmer JB. DNA vaccines. Mechanisms for generation of immune responses. Adv Exp Med Biol 1998; 452:187-191.
43. 43 Huygen K. DNA vaccines: application to tuberculosis. Int J Tuberc Lung Dis 1998; 2:971-978. A good review on DNA vaccines for tuberculosis.
44. 44 Lee BY, Horwitz MA. T-cell epitope mapping of the three most abundant extracellular proteins of Mycobacterium tuberculosis in outbred guinea pigs. Infect Immun 1999; 67:2665-2670.
45. 45 Coler RN, Skeiky YA, Vedvick T, Bement T, Ovendale P, Campos-Neto A, et al. Molecular cloning and immunologic reactivity of a novel low molecular mass antigen of Mycobacterium tuberculosis. J Immunol 1998; 161:2356-2364.
46. 46 Tanghe A, Lefevre P, Denis O, D'Souza S, Braibant M, Lozes E, et al. Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors. J Immunol 1999; 162:1113-1119.
47. 47 Bonato VL, Lima VM, Tascon RE, Lowrie DB, Silva CL. Identification and characterization of protective T cells in hsp65 DNA-vaccinated and Mycobacterium tubercutosis-infected mice. Infect Immun 1998; 66:169-175.
48. 48 Mohagheghpour N, Gammon D, Kawamura LM, van Vollenhoven A, Benike CJ, Engleman EG. CTL response to Mycobacterium tuberculosis: identification of an immunogenic epitope in the 19-kDa lipoprotein. J Immunol 1998; 161:2400-2406.
49. 49 Lalvani A, Brookes R, Wilkinson RJ, Malin AS, Pathan AA, Andersen P, et al. Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. Proc Natl Acad Sci USA 1998; 95:270-275.
50. 50 Demangel C, Bean AG, Martin E, Feng CG, Kamath AT, Britton WJ. Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bovis Bacillus Calmette Guérin-infected dendritic cells. Eur J Immunol 1999; 29:1972-1979.
51. 51 Hess J, Kaufmann SH. Live antigen carriers as tools for improved antituberculosis vaccines. FEMS Immunol Med Microbiol 1999; 23:165-173.
52. 52 Jackson M, Phalen SW, Lagranderie M, Ensergueix D, Chavarot P, Marchal G, et al. Persistence and protective efficacy of a Mycobacterium tuberculosis auxotroph vaccine. Infect Immun 1999; 67:2867-2873. First demonstration of a M. tuberculosis auxotroph as vaccine candidate.
53. 53 Gupte MD, Vallishayee RS, Anantharaman DS, Nagaraju B, Sreevatsa S, Balasubramanyam S, et al. Comparative leprosy vaccine trial in south India. Indian J Lepr 1998; 70:369-388.
54. 54 Wong DK, Lee BY, Horwitz MA, Gibson BW. Identification of fur, aconitase, and other proteins expressed by Mycobacterium tuberculosis under conditions of low and high concentrations of iron by combined two-dimensional gel electrophoresis and mass spectrometry. Infect Immun 1999; 67:327-336.
55. 55 Sonnenberg MG, Belisle JT. Definition of Mycobacterium tuberculosis culture filtrate proteins by two-dimensional polyacrylamide gel electrophoresis, N-terminal amino acid sequencing, and electrospray mass spectrometry. Infect Immun 1997; 65:4515-4524.
56. 56 Marques MA, Chitale S, Brennan PJ, Pessolani MC. Mapping and identification of the major cell wall-associated components of Mycobacterium leprae. Infect Immun 1998; 66:2625-2631.
57. 57 Flynn JL, Scanga CA, Tanaka KE, Chan J. Effects of aminoguanidine on latent murine tuberculosis. J Immunol 1998; 160:1796-1803.
58. 58 Scanga CA, Mohan VP, Yu K, Joseph H, Chan J, Flynn JL. Reactivation of latent tuberculosis: Variations on the Cornell model. Infect Immun 1999; 67:4531-4538. This paper presents results of detailed analyses on variations of the Cornell model of murine tuberculosis latency, and should be helpful for experimental design when using this system.
59. 59 Parrish NM, Dick JD, Bishai WR. Mechanisms of latency in Mycobacterium tuberculosis. Trends Microbiol 1998; 6:107-112.
60. 60 MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan CF. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci USA 1997; 94:5243-5248.
61. 61 Chan J, Flynn J. Nitric oxide in Mycobacterium tuberculosis infection. In Fang F (editor). Nitric oxide and infection. New York: Plenum Publishing Corporation 1999; 281-310.
62. 62 Adams LB, Mason CM, Kolls JK, Scollard D, Krahenbuhl JL, Nelson S. Exacerbation of acute and chronic murine tuberculosis by administration of a tumor necrosis factor receptor-expressing adenovirus. J Infect Dis 1995; 171:400-405.
63. 63 Mohan VP et al. 34th US Japan Cooperative Medical Science Program; San Francisco, 27-30 June 1999; Maryland, USA: National Institute of Allergy and Infections, National Institute of Health; in press.
64. 64 Scanga CA et al. 34th US Japan Cooperative Medical Science Program; San Francisco, 27-30 June 1999; Maryland, USA: National Institute of Allergy and Infections, National Institute of Health; in press.
65. 65 Yuan Y, Crane DD, Barry CE, III. Stationary phase-associated protein expression in Mycobacterium tuberculosis: function of the mycobacterial alpha-crystallin homolog. J Bacteriol 1996; 178:4484-4492.
66. 66 Yuan Y, Crane DD, Simpson RM, Zhu YQ, Hickey MJ, Sherman DR, Barry CE, III. The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages, Proc Natl Acad Sci USA 1998; 95:9578-9583.
67. 67 Cunningham AF, Spreadbury CL. Mycobacterial stationary phase induced by low oxygen tension: cell wall thickening and localization of the 16-kilodalton alpha-crystallin homolog. J Bacteriol 1998; 180:801-808. Excellent discussion on alpha-crystallin in the context of latency.
68. 68 Bentrup KH et al. 34th US Japan Cooperative Medical Science Program; San Francisco, 27-30 June 1999; Maryland, USA: National Institute of Allergy and Infections, National Institute of Health; in press.
69. 69 Murthy PS, Sirsi M, Ramakrishnan T. Effect of age on the enzymes of tricarboxylic acid and related cycles in Mycobacterium tuberculosis H37Rv. Am Rev Respir Dis 1973; 108:689-690.
70. 70 Wayne LG, Lin KY. Glyoxylate metabolism and adaptation of Mycobacterium tuberculosis to survival under anaerobic conditions. Infect Immun 1982; 37:1042-1049.
71. 71 Gomez JE, Chen JM, Bishai WR. Sigma factors of Mycobacterium tuberculosis. Tuber Lung Dis 1997; 78:175-183.
72. 72 Collins DM, Kawakami RP, de Lisle GW, Pascopella L, Bloom BR, Jacobs Wr, Jr. Mutation of the principal sigma factor causes loss of virulence in a strain of the Mycobacterium tuberculosis complex. Proc Natl Acad Sci USA 1995; 92:8036-8040.
73. 73 Smith I, Dussurget O, Rodriguez GM, Timm J, Gomez M, Dubnau J, et al. Extra and intracellular expression of Mycobacterium tuberculosis genes. Tuber Lung Dis 1998; 79:91-97.
74. 74 DeMaio J, Zhang Y, Ko C, Bishai WR. Mycobacterium tuberculosis sigF is part of a gene cluster with similarities to the Bacillus subtilis sigF and sigB operons. Tuber Lung Dis 1997; 78:3-12.
75. 75 Michele TM, Ko C, Bishai WR. Exposure to antibiotics induces expression of the Mycobacterium tuberculosis sigF gene: implications for chemotherapy against mycobacterial persistors. Antimicrob Agents Chemother 1999; 43:218-225.
76. 76 Chen P et al. American Society for Microbiology 99th General Meeting; Chicago, 31 May 1999. Abstract U-101; Washington, DC: ASM Press; 1999.
77. 77 Chen P et al. 34th US Japan Cooperative Medical Science Program; San Francisco, 27-30 June 1999; Maryland, USA: National Institute of Allergy and Infections, National Institute of Health; in press.